Tag: Augmenix
Boston Scientific announces agreement to acquire Augmenix
Boston Scientific has announced that it has entered into a definitive agreement to acquire Augmenix, a privately-held company which has developed and commercialised the...
Augmenix announces first prostate cancer patients treated with SpaceOAR hydrogel in...
Augmenix, a medical technology company that develops, manufactures, and sells proprietary absorbable hydrogels that separate and protect organs at risk during radiotherapy and interventional...
